United States Market for Psoriatic Arthritis Pharmacotherapy

Availability of Novel Therapies Anticipated to Prompt Fresh Growth

Regular Price: USD 4,950

Special Price USD 3,713

25% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,713

PAY BY INVOICE

Be the first to review this product

This research service covers the United States psoriatic arthritis pharmaceuticals market from 2009 to 2017, with 2011 as the base year. The focus of this study is prescription therapeutics prescribed and used as add-on therapy to background standard of care. Included in the study are products on the market and products in development as well as patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed. The market is segmented by classes of drug: tumor necrosis factor (TNF) inhibitors, non-TNF biologics and novel oral disease-modifying antirheumatic drugs (DMARDs).

Table of Contents

United States Market for Psoriatic Arthritis Pharmacotherapy, Psoriatic Arthritis Pharmacotherapeutics MarketResearch ServiceExecutive SummaryMarket OverviewPsoriatic Arthritis Pharmacotherapeutics MarketExternal Challenges: Drivers and RestraintsForecast and TrendsDemand AnalysisMarket Share and Competitive AnalysisUnited States Market for Psoriatic Arthritis Pharmacotherapeutics: Analysis by Market SegmentTNF Inhibitor SegmentNon-TNF Biologics SegmentNovel Oral DMARDs SegmentThe Last WordThree Big PredictionsAppendixAppendix




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 13-Dec-17

Region : North America

Release Date : 13-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.